|
The term " lymphocytic
interstitial pneumonia" was introduced by Leibow and Carrington to
describe a diffuse lymphocytic infiltrate.
Follicular
bronchitis/ bronchiolitis was a term that was introduced to describe a
predominantly peribronchial lymphocytic infiltrate with abundant germinal
centres.
Lymphocytic interstitial pneumonia (LIP) and
follicular bronchiolitis (FB) represent overlapping histological
patterns caused by a response of the pulmonary immune system to variety of
unknown factors , with lymphoid hyperplasia the underlying pathogenic
mechanism in both conditions.
| Histopathological
images of
Lymphocytic Interstitial Pneumonia:
Diagram:click
;
Image1: click
;
Image2: click
Expansion of the
interstitium by lymphoid infiltrate. The infiltrate does not destroy
the alveolar architecture. Some lymphoid follicles are also present.B-cell
aggregates are CD20(+).
The interstitial infiltrate consisting of predominantly T-cells are
CD3(+).
Histopathological images of
Follicular Bronchiolitis:
Diagram:click
;
Image1: click
;
Image2: click
Lymphoid follicles
cause narrowing of bronchial lumen. FB and LIP are thought to
represent overlapping histopathological patterns of lymphoid
hyperplasia within the pulmonary immune system. |
Clinical
presentation:
Average age at presentation is about 50 years
in both conditions.
These are more common in females.
There is an association with
connective tissue disorders, and immunodeficiency.
LIP alone is reported to carry a low risk of lymphomatous transformation.
Presenting symptoms include dyspnoea,
cough, recurrent upper respiratory tract infections and chest pain, with
haemoptysis in some cases.
Microscopic features:
In LIP:
The main feature is an
interstitial infiltrate of small lymphocyte, plasma cells and histiocytes
.
Germinal centers are identified
in a number of cases.
Granuloma formation is sometimes noted.
In FB:
There are abundant peribronchiolar germinal centers and the
airway lumen is often compressed.
Most cases show extension of a
mixed lymphoid infiltrate into the interstitium, emphasizing the overlap
between the two conditions.
Immunohistochemistry:
Shows that
in LIP, CD20-positive B-cells are mainly limited to the germinal centers, whilst
the interstitial lymphocytes are predominantly T-cells mixed with plasma
cells.
Amplification of the immunoglobulin heavy
chain gene using polymerase chain reaction has shown a polyclonal pattern
in both FB and LIP.
Visit:
Pulmonary Lymphoproliferative Disease
;
Idiopathic Pulmonary Fibrosis
;
Usual Interstitial Pneumonia (UIP)
;
Non-specific interstitial pneumonia (NSIP)
;
Desquamative interstitial pneumonia (DIP)
;
Respiratory bronchiolitis-interstitial lung
disease (RBILD) ;
Acute interstitial pneumonia (AIP)/organizing
diffuse alveolar damage DAD) ;
Differential Diagnosis
:
1)
Pulmonary B-cell
non-Hodgkin’s MALT lymphomas
:
It is usually difficult
to distinguish lymphoid hyperplasia (LIP / FB) from low-grade lymphoma in small biopsies.
Clinical and imaging data may be required
to favour one diagnosis or the other . Biopsy is often required to confirm
the diagnosis.
Histopathologically, lymphoma infiltrates and destroy the
alveolar architecture more than LIP. There is greater widening of alveolar
septa by the lymphoid infiltrate.
Lymphoepithelial lesions
are less frequently seen.
Immunohistochemistry
:
B-cells tend to
infiltrate widely in lymphomas, This is an useful distinguishing factor.
The
pattern of a reactive infiltrate is of aggregated B-cells that are usually peribronchial or septal in distribution, with a predominantly T-cell
infiltrate in the alveolar interstitium.
Further evidence of lymphoma can
be found by identifying light chain restriction using immunohistochemistry
or monoclonality using PCR.
The differential diagnosis of high-grade
lymphoma is usually carcinoma . These are differentiated by using standard epithelial and lymphoid markers.
2)
Extrinsic Allergic Alveolitis
:
LIP may also be histologically
indistinguishable from extrinsic allergic alveolitis. In LIP there
is
absence of an environmental allergen.
There is also some histological and clinical overlap with
‘cellular’ cases of non-specific interstitial pneumonia.
Therefore, a combination of clinical, radiological and histological
information is important for correct classification and appropriate
management of the patients.
|
Lymphoid interstitial pneumonia: a narrative review.
Chest. 2002 Dec;122(6):2150-64.
Lymphoid
interstitial pneumonia (LIP) is regarded as both a disease and a
nonneoplastic, inflammatory pulmonary reaction to various external
stimuli or systemic diseases. It is an uncommon condition with
incidence and prevalence rates that are largely unknown. Liebow and
Carrington originally classified LIP as an idiopathic interstitial
pneumonia in 1969. Although LIP had since been removed from that
category, the most recent consensus classification sponsored by the
American Thoracic Society and the European Respiratory Society
recognizes that some cases remain idiopathic in origin, and its
clinical, radiographic, and pathologic features warrant the return of
LIP to its original classification among the idiopathic interstitial
pneumonias. LIP also belongs within a spectrum of pulmonary
lymphoproliferative disorders that range in severity from benign,
small, airway-centered cellular aggregates to malignant lymphomas. It
is characterized by diffuse hyperplasia of bronchus-associated
lymphoid tissue. The dominant microscopic feature of LIP is a diffuse,
polyclonal lymphoid cell infiltrate surrounding airways and expanding
the lung interstitium. Classically, LIP occurs in association with
autoimmune diseases, most often Sjogren syndrome. This has led to
consideration of an autoimmune etiology for LIP, but its pathogenesis
remains poorly understood. Persons who are seropositive for HIV, and
children in particular, are at increased risk of acquiring LIP. Some
studies suggest causal roles for both HIV and Epstein-Barr virus. The
incidence of LIP is approximately twofold greater in women than men.
The average age at diagnosis is between 52 years and 56 years.
Symptoms of progressive cough and dyspnea predominate. There is great
variability in the clinical course of LIP, from resolution without
treatment to progressive respiratory failure and death. Although LIP
is often regarded as a steroid-responsive condition, and oral
corticosteroids continue to be the mainstay of therapy, response is
unpredictable. Approximately 33 to 50% of patients die within 5 years
of diagnosis, and approximately 5% of cases of LIP transform to
lymphoma.
Update on lymphoid interstitial pneumonitis.Curr
Opin Pulm Med. 1996 Sep;2(5):429-33
Lymphoid
interstitial pneumonitis (LIP) involves a clinicopathologic pattern of
pulmonary disease characterized by diffuse interstitial reactive
lymphoid infiltrates. In adults, it occurs most commonly in autoimmune
diseases, such as Sjogren's syndrome (0.9% of these patients) and
primary biliary cirrhosis, whereas in children it is usually seen in
HIV infection. Dysproteinemias (hyper- and hypogammaglobulinemia) are
found in more than 60% of patients. Children can show
CD8-lymphocytosis in bronchoalveolar lavage fluid, lung tissue,
peripheral blood, and salivary gland, associated with HLA-DR5
haplotype. Radiographically, most patients with LIP have
reticulonodular infiltrates, with or without patchy areas of
consolidation. CT scans can show both small nodular and ground glass
patterns, patterns that are diagnostically nonspecific. Reduced lung
volumes and diffusing capacities are consistent and sensitive
indicators of disease in LIP. In an experimental model, diffusing
capacity was the single most sensitive functional index of disease
progression. Microscopically, LIP is part of a spectrum of pulmonary
lymphoid proliferations, ranging from follicular bronchitis-bronchiolitis
and pulmonary lymphoid hyperplasia (the latter in AIDS patients),
proliferations largely limited to airways, to low-grade malignant
lymphoma. These patterns may be difficult to differentiate from each
other. It appears that LIP sometimes evolves to lymphoma; the
frequency of this evolution is probably low but is difficult to assess
because low-grade lymphomas may mimic LIP. A relatively high frequency
of LIP patients have Epstein-Barr virus DNA in their lungs but not all
patients with LIP show this finding, suggesting other possible
etiologies.
Reactive
pulmonary lymphoid disorders.
Histopathology. 1995 May;26(5) : 405-12.
The two main
reactive pulmonary lymphoid disorders are lymphoid interstitial
pneumonia and follicular bronchitis/bronchiolitis, both pathological
entities with a variety of aetiologies. We reviewed the morphological
and immunohistochemical features of 26 cases with one or other of
these two diagnoses, to explore the possibility that they represented
overlapping patterns of hyperplasia of the bronchopulmonary immune
system. The polymerase chain reaction was used to determine the
clonality of the infiltrates. Histologically, there was a spectrum of
changes with two main components. An interstitial infiltrate of mainly
T lymphocytes, plasma cells and histiocytes predominated in lymphoid
interstitial pneumonia, whilst lymphoid follicles predominated around
airways in follicular bronchitis/bronchiolitis. Classification of the
disorder rested on which component the pathologists believed to be
dominant. In two cases, histology and immunohistochemistry suggested
lymphoma, and in one of these cases this diagnosis was confirmed by
the polymerase chain reaction. One case of lymphoid interstitial
pneumonia produced three bands. The remainder produced polyclonal
patterns when samples were adequate. Clinically, there was no clear
difference between patients with the two disorders, or patients with
pathological features of both. |
|